Treatments

Inside the First FDA-Approved CAR T-Cell Therapy

ALL patients who haven’t responded to standard care have new options on the horizon, including a type of immunotherapy called CAR T-cell therapy. Learn more from Dr. Michael Deininger.

Andrew Schorr, Michael Deininger, MD, PhD

Treatments

How Can Acute Lymphoblastic Leukemia Treatment Be Tailored?

Dr. Elias Jabbour from The University of Texas MD Anderson Cancer Center explains how patient's individual circumstances affect treatment decisions. Watch to learn from an ALL expert.

Dr Elias Jabbour

Upcoming Events

See all events

Apr 9 2020

Thursday, April 9, 2020

Time: 2:00 PM – 2:30 PM Pacific Time (US and Canada)

What Should Acute Leukemia Patients Know About the Coronavirus?

Join two leading experts from MD Anderson, Houston - Dr. Tapan Kadia and Dr. Naval Daver - as they discuss the issues and concerns patients and loved ones dealing with acute types of leukemia might have in the current coronavirus crisis. Please send questions in advance to [email protected] info

Topic Area: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia

Type: Online

Time: 2:00 PM – 2:30 PM Pacific Time (US and Canada)

Learn More